alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit
10.2


 





 





2019
Bryan Lewis Bonus Compensation Plan


 


On-target
bonus compensation for 2019 shall be 50% of salary. 75% of the on-target bonus will be a cash component based upon the percentage
of 2019 budgeted EBITDA achieved. 25% of the on-target bonus will be a discretionary award of Restricted Stock Units (RSUs) from
the 2015 Omnibus Incentive Plan, as amended, based on the percentage completion of the targets listed in Appendix A.


 


For
the avoidance of doubt, if the on-target bonus were $75,000, and all targets are achieved, then:


 


	 	●	$56,250
    would be the cash component
	 	●	$18,750
    would be the value of the RSUs awarded


 


The
percentage payout for the cash component will be based on the percentage of EBITDA target achieved in the following table:


 


	 

        Budgeted

        EBITDA
        Loss
	 

        Percentage
        of

        EBITDA
        Target
	Minimum

        Additional

        EBITDA
	Percentage
                                         of

        On-Target

        Bonus
        Paid

	 	Less
    than 90%	 	0%
	 	90%
    - 94.99%	$
    (229,889.00)	25%
	 	95%
    - 99.99%	$
    (114,944.50)	90%
	$(2,298,890)	100%
    - 104.99%	$-	100%
	 	105%
    - 109.99%	$114,944.50	105%
	 	110%
    - 114.99%	$229,889.00	110%
	 	115%
    - 119.99%	$344,833.50	115%
	 	120%
    - 124.99%	$459,778.00	125%
	 	125%
    - 129.99%	$574,722.50	150%
	 	130%
    and Greater	$689,667.00	175%
	 	 	 	 
	 	On-Target	 	 
	 	Indicates
    EBITDA Positive in Q4 2019	 


 


All
EBITDA targets are net of the bonus expense.








 


	 	●	The EBITDA will be determined
                                         by Management as part of the 2019 year-end close with final determination to be made
                                         by the Board




	 	●	The
    bonus amount will be confirmed by the board no later than the March 2020 Board meeting, payable on the next payroll date.
	 	●	The
    executive team member must be an active employee on the date of payment in order to receive the bonus


 


	Signature	/s/
    Bryan Lewis	 	Date
    4/15/2019


 


Intellicheck,
Inc – Company Confidential


 




    	 	 	 



    	 



    

 


 


Appendix
A


 


Bryan
Lewis


 


	 	1)	Implement
    company-wide review process to be completed no later than September 30 2019
	 	2)	Strategy
    document detailing expansion plans, acquisition targets growth initiatives for 2019 and beyond delivered to Board by the June
    First Wednesday meeting.
	 	3)	Citibank
    closed and paying at least contracted monthly minimum by June 30, 2019 and either of Capital One or Synchrony closed and paying
    contract minimum by September 30 2019


 


Intellicheck,
Inc – Company Confidential
IN RE K.F.

No. COA04-360.

Court of Appeals of North Carolina.

Filed April 19, 2005.

Certification Date May 9, 2005.

Appeal from Wilkes (01J159, 01J160).

Case reported without published opinion. Affirmed.
[Cite as State v. Sellers, 123 Ohio St.3d 128, 2009-Ohio-4907.]

T HE S TATE OF O HIO , A PPELLANT , v . S ELLERS , A PPELLEE . [Cite as State v. Sellers, 123 Ohio St.3d 128, 2009-Ohio-4907.] Court of appeals’ judgment affirmed on the authority of State v. Harris. (No. 2009-0547

— Submitted August 11, 2009

— Decided September 22, 2009.)
A PPEAL from the Court of Appeals for Cuyahoga County, No. 91043,
2009-Ohio-485.

__________________ {¶ 1} The judgment of the court of appeals is affirmed on the authority
of State v. Harris , 122 Ohio St.3d 373, 2009-Ohio-3323, 911 N.E.2d 882

. M OYER , C.J., and P FEIFER , L UNDBERG S TRATTON , O’C ONNOR , O’D ONNELL , L ANZINGER , and C UPP , JJ., concur.

__________________ William D. Mason, Cuyahoga County Pr osecuting Attorney, and Kristen L. Sobieski, Assistant Prosecuting Attorney, for appellant. Thomas Rein, for appellee.

__________________
### IN THE SUPREME COURT OF THE STATE OF MONTANA DA 24
- 0321 In the Marriage of MITCHELL BURGARD,

Petitioner and Appellee,
v. STACY JACOBSEN,

Respondent and Appellant. ORDER OF MEDIATOR APPOINTMENT

This appeal being subject to M.R.App.P. 7, and the parties having failed to jointly and timely select a mediator under M.R.App.P., 7(4),(c), IT IS ORDERED THAT **Vanessa M.**  **Ceravolo, Esq.,**  whose name appears next on the list of attorneys desiring appointment as mediators for Domestic Relations appeals which is maintained pursuant to M.R.App.P., 7(4)(e), is hereby appointed to conduct the mediation process required by M.R.App.P., 7(5), and IT IS FURTHER ORDERED that the time periods set forth in M.R.App.P., 7(5)(d) shall run from the date of this order of appointment. A true copy of this order is being mailed to counsel of record for the parties, or to the parties individually if not represented by counsel, on the date hereof. DATED this June 12, 2024.

Bowen Greenwood, Clerk of the Supreme Court
c: Mary Sillstrop Obermiller, Misty D. Gaubatz, Vanessa M. Ceravolo, Esq. 06/12/2024

Case Number: DA 24-0321
This disposition is not appropriate for publication and is not precedent *

except as provided by 9th Cir. R. 36-3.

The panel unanimously concludes this case is suitable for decision **

without oral argument. See Fed. R. App. P. 34(a)(2).

NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

 FOR THE NINTH CIRCUIT

BERTA DE JESUS AMAYA-DIAZ;

NUBIA LISSETTE AMAYA-DIAZ,

 Petitioners,

 v.

ERIC H. HOLDER, Jr., Attorney General,

 Respondent.

No. 10-71640

Agency Nos. A099-523-564

 A099-523-565

MEMORANDUM*

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted July 12, 2011** 

Before: SCHROEDER, ALARCÓN, and LEAVY, Circuit Judges.

Berta de Jesus Amaya-Diaz and Nubia Lissette Amaya-Diaz, natives and

citizens of El Salvador, petition for review of the Board of Immigration Appeals’

(“BIA”) order dismissing their appeal from an immigration judge’s (“IJ”) decision

denying their application for asylum, withholding of removal, and relief under the

FILED

JUL 19 2011

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 10-71640

Convention Against Torture (“CAT”). Our jurisdiction is governed by 8 U.S.C.

§ 1252. We review for substantial evidence factual findings, INS v. EliasZacarias, 502 U.S. 478, 481 & n.1 (1992), and we deny in part and dismiss in part

the petition for review. 

Substantial evidence supports the BIA’s finding that petitioners failed to

demonstrate that the gang members harmed them and tried to recruit them on

account of a political opinion. See Barrios v. Holder, 581 F.3d 849, 855-56 (9th

Cir. 2009); Ramos-Lopez v. Holder, 563 F.3d 855, 862 (9th Cir. 2009). We lack

jurisdiction to consider petitioners’ contention that they are members of a

particular social group of young women who refuse to live under the threat of

sexual violence or young girls who are vehemently opposed to gang recruitment,

extortion, and female sexual coercion because they did not raise these distinct

social group claims to the IJ or BIA. See Barron v. Ashcroft, 358 F.3d 674, 678

(9th Cir. 2004). Petitioners do not challenge in their opening brief the BIA’s

conclusion that young women who have been abandoned and receive monthly

income are not a particular social group. See Martinez-Serrano v. INS, 94 F.3d

1256, 1259-60 (9th Cir. 1996). Accordingly, petitioners’ asylum and withholding

of removal claims fail. See Ochoa v. Gonzales, 406 F.3d 1166, 1172 (9th Cir.

2005). 
3 10-71640

Finally, substantial evidence also supports the BIA’s denial of CAT relief

because petitioners failed to establish that it is more likely than not they will be

tortured by or with the acquiescence of the government of El Salvador. See Silaya

v. Mukasey, 524 F.3d 1066, 1073 (9th Cir. 2008). 

PETITION FOR REVIEW DENIED in part; DISMISSED in part.
<Page>
                                                                    EXHIBIT 11.1



EXHIBIT 11.1 Statement re computation of per share earnings

Earnings per share - basic, are based upon the Company's weighted average number
of common shares outstanding. The 3,824,511 contingent shares which were placed
in escrow at the time of the merger and retired, were excluded from the
computation.
<TABLE>
<CAPTION>

                                                              2002                2001                2000
                                                              ----                ----                ----
                                                                 (In thousands - except per share data)
<S>                                                          <C>                 <C>                 <C>
Net Income                                                   $2,370              $1,295              $1,041
                                                             ======              ======              ======
Weighted average shares outstanding - basic                  10,049              10,956              11,346
Shares issuable upon exercise of dilutive options               209                 191                 100
Less: shares assumed repurchased                                (69)                (56)                 (1)
                                                               ----                ----                 ---
Weighted average shares outstanding - diluted                10,189              11,091              11,445
                                                             ======              ======              ======
Earnings per share - basic                                    $0.24               $0.12               $0.09
Earnings per share - diluted                                  $0.23               $0.12               $0.09
</TABLE>
EXHIBIT 32.2



CERTIFICATIONS PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of National Beef Packing Company, LLC (the Company) on Form 10-Q for the period ended February 28, 2004 as filed
with the Securities and Exchange Commission on the date hereof (the Report), I, Jay D. Nielsen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge:



(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.



By:

/s/ JAY D. NIELSENJay D. Nielsen Chief Financial Officer




Date: April 13, 2004
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                         278,514
<SECURITIES>                                21,341,949
<RECEIVABLES>                                  498,296
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              22,137,122
<CURRENT-LIABILITIES>                          518,288
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  21,618,834
<TOTAL-LIABILITY-AND-EQUITY>                22,137,122
<SALES>                                              0
<TOTAL-REVENUES>                             1,309,281
<CGS>                                                0
<TOTAL-COSTS>                                  116,963
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              1,192,318
<INCOME-TAX>                                 1,192,318
<INCOME-CONTINUING>                          1,192,318
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,192,318
<EPS-BASIC>                                        .97
<EPS-DILUTED>                                        0




</TABLE>
```

                                  EXHIBIT 32.1

                        CERTIFICATION OF CEO PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report on Form 10-Q of Northstar
Realty Finance Corp. (the "Company") for the quarterly period ended September
30, 2004 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), David T. Hamamoto, as Chief Executive Officer of the Company,
hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his
knowledge:

         (1) The Report fully complies with the requirements of Section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.

Date:    December 30, 2004              By: /s/ David T. Hamamoto
                                            ---------------------------
                                            Name: David T. Hamamoto
                                            Title: Chief Executive Officer

This certification accompanies the Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 of the
Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained
by the Company and furnished to the Securities and Exchange Commission or its
staff upon request.
```
**Exhibit 32.1**

 

**Certification Pursuant To18 U.S.C. Section 1350As Adopted Pursuant ToSection 906 of the Sarbanes-Oxley Act of 2002**

 

In connection with theQuarterly Report of Hospira, Inc. (the “Company”) on Form 10-Q forthe period ended June 30, 2008 as filed with the Securities and ExchangeCommission (the “Report”), I, Christopher B. Begley, Chairman and ChiefExecutive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, asadopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)   The Report fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Actof 1934; and

 

(2)   The information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 

 
| /s/  CHRISTOPHER  B. BEGLEY |   |
|---------------------------------------|--------|
| Christopher  B. Begley                |   |
| Chairman  and Chief Executive Officer |   |
| August 6,  2008                  |   |

 

 

----
# L_2018060EN.01005701.xml

| 2.3.2018 | EN | Official Journal of the European Union | L 60/57 |
| --- | --- | --- | --- |

2.3.2018

EN

Official Journal of the European Union

L 60/57

---

Corrigendum to Guideline (EU) 2016/2249 of the European Central Bank of 3 November 2016 on the legal framework for accounting and financial reporting in the European System of Central Banks (ECB/2016/34)

(
  Official Journal of the European Union L 347 of 20 December 2016
  )

On page 43, Article 13:

for:

‘2.   In derogation from Article 3(b) and Articles 9(4), 15(1) and 17(2), the following alternative treatment may be applied to the valuation of synthetic instruments:’,

read:

‘2.   In derogation from Articles 3(2), 9(4), 15(1) and 17(2), the following alternative treatment may be applied to the valuation of synthetic instruments:’.

---
I 

110TH CONGRESS 

2D SESSION H. R. 4963 

To extend the temporary suspension of duty on Chloroacetic acid, sodium 

salt. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 15, 2008 

Mrs. MYRICK introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To extend the temporary suspension of duty on Chloroacetic 

acid, sodium salt. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CHLOROACETIC ACID, SODIUM SALT. 

4 (a) IN GENERAL.—Heading 9902.12.34 of the Har5 monized Tariff Schedule of the United States (relating to 

6 Chloroacetic acid, sodium salt) is amended by striking 

7 ‘‘12/31/2009’’ and inserting ‘‘12/31/2011’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to goods entered, or withdrawn from 


ccoleman on PRODPC75 with BILLS
2 

•HR 4963 IH

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


ccoleman on PRODPC75 with BILLS
**Exhibit 31.2****CERTIFICATION**I, Steven M. Van Dick, certify that:1. I have reviewed this Quarterly Report on Form 10-Q of Hansen Medical, Inc.;2. Based on my knowledge, this report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect to the period covered by thisreport;3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in this report;4. The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period in which thisreport is being prepared;  (b) Evaluated the effectiveness of the registrant’s disclosure controls and proceduresand presented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this report based on suchevaluation; and  (c) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and5. The registrant’s other certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely to adversely affectthe registrant’s ability to record, process, summarize and report financial information;and  (b) Any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.November 2, 2007        /s/   Steven M. Van Dick   Vice President and Chief Financial Officer   (Principal Financial and Accounting Officer)
Exhibit 32.2





CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO TITLE 18,


UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





I, Michael C. Greiner, Executive Vice President and Chief Financial Officer of ANGIODYNAMICS, Inc. (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that, to the best of my knowledge:


1.the quarterly report on Form 10-Q/A of the Company for the fiscal quarter ended August 31, 2016 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Date: July 25, 2017





/ s / Michael C. GreinerMichael C. Greiner, Executive Vice President andChief Financial Officer
<PAGE>
                                                                               .
                                                                               .
                                                                               .

                                                                    EXHIBIT 11.1

                           COAST DENTAL SERVICES, INC.
                    COMPUTATION OF PER SHARE EARNINGS (LOSS)

<TABLE>
<CAPTION>
                                                                           Year Ended December 31,
                                                               -----------------------------------------------
                                                                   2002             2001             2000
                                                               -------------    -------------    -------------
<S>                                                            <C>              <C>              <C>
Net loss ...................................................   $  (3,943,797)   $  (9,366,661)   $  (1,263,940)
                                                               =============    =============    =============

Shares:
Basic weighted average number of shares outstanding ........       2,091,223        2,091,223        2,097,611
Additional shares issuable under stock options for
  diluted earnings per share ...............................              --               --               --
                                                               -------------    -------------    -------------
Diluted weighted average number of shares outstanding ......       2,091,223        2,091,223        2,097,611
                                                               =============    =============    =============

Basic loss per share:
     Net loss ..............................................   $       (1.89)   $       (4.48)   $       (0.60)
                                                               =============    =============    =============
Diluted loss per share:
     Net loss ..............................................   $       (1.89)   $       (4.48)   $       (0.60)
                                                               =============    =============    =============
</TABLE>